Neither PDAC nor invasive IPMN cases showed significant differences in the IL‐18/IL‐18BP ratio in terms of any prognostic factor examined (Figure 5E and supplementary material, Figure S6F). This evidence concerns the gene IL18 and pancreatic intraductal papillary-mucinous neoplasm.